Back
Acasti Pharma Vs. Nike Industry Stock Comparison
Sell
40
ACST
Acasti Pharma
Last Price:
2.88
Seasonality Move:
0.26%
Sell
17
NKE
Nike
Last Price:
75.45
Seasonality Move:
6.25%
Sell
40
Acasti Pharma (ACST)
is a Sell
Is Acasti Pharma a Buy, Sell or Hold?
- The current Acasti Pharma [ACST] share price is $2.90. The Score for ACST is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ACST is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Nike (NKE)
is a Sell
Is Nike a Buy, Sell or Hold?
- The current Nike [NKE] share price is $75.24. The Score for NKE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- NKE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ACST Stock Price Chart
What is Acasti Pharma's stock price today?
-
The Acasti Pharma share price today is $2.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACST is experiencing slight selling pressure.
NKE Stock Price Chart
ACST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 44.08 | Sell |
Chaikin Money Flow: | -5084 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.85 - 3.23) | Sell |
Bollinger Bands (100): | (2.81 - 3.39) | Sell |
NKE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.95 | Sell |
Relative Strength Index (14 RSI): | 21.04 | Sell |
Chaikin Money Flow: | -8144437 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (84.75 - 98.87) | Sell |
Bollinger Bands (100): | (89.12 - 101.24) | Sell |
ACST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.98 | Sell |
20-day SMA: | 3.1 | Sell |
50-day SMA: | 2.92 | Sell |
200-day SMA: | 2.75 | Buy |
8-day EMA: | 2.97 | Sell |
20-day EMA: | 3.01 | Sell |
50-day EMA: | 3 | Sell |
200-day EMA: | 2.93 | Sell |
NKE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.46 | Sell |
20-day SMA: | 91.29 | Sell |
50-day SMA: | 92.23 | Sell |
200-day SMA: | 99.9 | Sell |
8-day EMA: | 82.83 | Sell |
20-day EMA: | 88.48 | Sell |
50-day EMA: | 91.81 | Sell |
200-day EMA: | 99.03 | Sell |
Acasti Pharma Earnings Growth & ACST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.10 per share, an increase this year of $1.16 per share, and an increase next year of $0.30 per share.
Nike Earnings Growth & NKE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.48 per share, and a decrease next year of $0.52 per share.
Acasti Pharma Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nike Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |